Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Symptoms and General Pathology

Lung Neoplasms

Postoperative Complications

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Anti-Inflammatory Agents

Respiratory System Agents

All Drugs and Chemicals

Reproductive Control Agents

Budesonide

Ipratropium

Terbutaline

Bronchodilator Agents

Anti-Asthmatic Agents

Glucocorticoids

Hormones

Hormone Antagonists

+terbutaline 5mg/2mL,BID+ipratropium 2 puff(40ug)BID

To test the hypothesis that nebulizer Pulmicort Respules could reduce post operation pulmonary complication incidence in primary lung cancer patients with COPD. Compare post-operation pulmonary complication incidence in two arms among primary lung cancer patients with COPD required single lobectomy from 3 days before operation to 7 days after operation.

Xiuyi Zhi, Professor

To test the hypothesis that nebulized Pulmicort Respules could reduce post operation pulmonary complication incidence in primary lung cancer patients with COPD. Compare post-operation pulmonary complication incidence in two treatment arms among primary lung cancer patients with COPD required single lobectomy from 3days before operation to 7 days after operation.

Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD

Efficacy of Nebulized Pulmicort Respules on Post Operation Pulmonary Complication During Pulmonary Single Lobectomy Surgery in Primary Lung Cancer Patients With COPD

Definition of post-operation pulmonary complication:

1. Pneumonia/other pulmonary infections, with X-ray evidence, fever and/or WBC\>15,000mL
2. Sputum retention:classified as purulent and the pour ability grade is 1 or 2
3. Acute respiratory failture or chronic respiratory failture
4. Atelectasis
5. Aerothorax:\>30% by X-ray; pulmonary embolism

Xiuyi Zhi

Professor

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD	NCT02504801	Post Operative ... Lung Cancer COPD	Budesonide	40 Years - 80 Years	Xuanwu Hospital, Beijing
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD	NCT02504801	Post Operative ... Lung Cancer COPD	Budesonide	40 Years - 80 Years	Xuanwu Hospital, Beijing

Spots Global Cancer Trial Database for primary lung cancer patients